Osteoblast-secreted BMP2, in turn, was found to activate the AKT/NFKB axis in prostate cancer cells, leading to enhanced migration of the cells via an activation of the transmembrane adhesion receptors integrin β1 and β3 [111]. The gene discussed is BMP2; the disease is prostate carcinoma.